.png)
.png)
Total amount raised
$341M
Latest funding date
2026-01-08
Location
Verana Health has successfully raised funds through six funding rounds, attracting a total of 15 investors, including notable names like Brook Byers and Transformational Healthcare. The company specializes in drug lifecycle management and medical practice, leveraging advanced AI and ML technology to provide actionable insights aimed at improving patient care.
What Is Verana Health?
Verana Health is a digital health company based in San Francisco, California, specializing in drug lifecycle management and medical practice. The company operates within the healthcare, analytics, biotechnology, and database industries, leveraging advanced AI and machine learning technologies to provide actionable insights aimed at improving patient care.
Founded with a mission to unlock real-world data to transform patient lives, Verana Health partners with leading medical societies and pharmaceutical organizations. The company has a workforce of 51-100 employees and maintains additional locations in New York and Knoxville.
How Much Funding Has Verana Health Raised?
- Series A
- Amount Raised: USD 1,000,000
- Date: January 2013
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To establish the company's initial operations and develop its core technology.
- Series B
- Amount Raised: USD 7,800,000
- Date: February 2015
- Lead Investors: Not publicly disclosed
- Participants: Biosys Capital, GE Ventures, Lagunita Biosciences, Waycross Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the company's technology and data capabilities.
- Series C
- Amount Raised: USD 30,000,000
- Date: July 2018
- Lead Investors: GV (formerly Google Ventures)
- Participants: Biomatics Capital, Brook Byers, GE Ventures, Lagunita Biosciences
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To rebrand the company and expand its capabilities and partnerships.
- Series D
- Amount Raised: USD 100,000,000
- Date: February 2020
- Lead Investors: GV (formerly Google Ventures)
- Participants: Bain Capital Ventures, Casdin Capital, Define Ventures, and existing investors
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance product development, expand data partnerships, and support the acquisition of PYA Analytics.
- Series E
- Amount Raised: USD 150,000,000
- Date: January 2022
- Lead Investors: Johnson & Johnson Innovation – JJDC, Inc. (JJDC); Novo Growth (arm of Novo Holdings)
- Participants: GV (formerly Google Ventures), Casdin Capital, Brook Byers, Breyer Capital, Merck Global Health Innovation Fund, Transformational Healthcare Venture Capital (THVC)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To advance life sciences product strategy, enhance value to healthcare providers, and expand data footprint.
- Undisclosed Round
- Amount Raised: USD 52,000,000
- Date: January 2026
- Lead Investors: Not publicly disclosed (existing institutional investors and industry veteran investors)
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: Committed in conjunction with Verana Health's merger with COTA, Inc. to expand its real-world data offerings across oncology and other specialties.
Total Amount Raised: At least USD 340,800,000 based on disclosed funding rounds. Additional rounds with undisclosed amounts may exist. Current Valuation: Not publicly disclosed.
Key Investors
- Johnson & Johnson Innovation (JJDC)
- Details: Johnson & Johnson Innovation – JJDC, Inc. is a division of Johnson & Johnson that focuses on accelerating early-stage innovation worldwide. It co-led Verana Health's $150M Series E round in January 2022.
- Investment Focus Areas: Healthcare, pharmaceuticals, medical devices, consumer health products.
- Notable Investments: Grail, Arcturus Therapeutics, Auris Health.
- Novo Holdings (Novo Growth)
- Details: Novo Holdings is a holding and investment company that manages the assets and wealth of the Novo Nordisk Foundation. Its growth-stage arm, Novo Growth, co-led Verana Health's Series E round.
- Investment Focus Areas: Life sciences, biotechnology, pharmaceuticals, medical technology.
- Notable Investments: Xellia Pharmaceuticals, Synlab, ERT.
- GV (formerly Google Ventures)
- Details: GV is the venture capital investment arm of Alphabet Inc. It led both the $30M Series C (2018) and the $100M Series D (2020) rounds for Verana Health.
- Investment Focus Areas: Technology, life sciences, healthcare, artificial intelligence, consumer products.
- Notable Investments: Uber, Slack, Nest.
- Casdin Capital
- Details: Casdin Capital is an investment firm focused on life sciences, biotechnology, and healthcare innovation. It participated in the Series D and Series E rounds.
- Investment Focus Areas: Life sciences, biotechnology, healthcare IT.
- Notable Investments: 10x Genomics, Twist Bioscience, Relay Therapeutics.
- Brook Byers
- Details: Brook Byers is a veteran venture capitalist known for his investments in healthcare and biotechnology sectors. He participated in the Series C and Series E rounds of Verana Health.
- Investment Focus Areas: Biotechnology, healthcare, life sciences.
- Notable Investments: Genentech, Hybritech, Athenahealth.
What's Next for Verana Health?
Verana Health stands at the cusp of significant opportunities, driven by its recent $150 million Series E funding. The company aims to advance its life sciences product and service strategy, enhance its value proposition to healthcare providers, and expand its data footprint through strategic partnerships. Leveraging its VeraQ platform and Qdata modules, Verana Health is poised to make substantial strides in clinical trials, software-as-a-service, and real-world evidence, particularly through the use of AI and natural language processing.
Future fundraising opportunities appear promising, given the strong backing from high-profile investors and the company's robust growth trajectory. As Verana Health continues to expand its technological capabilities and data partnerships, it may attract additional rounds of funding to support further innovation and market expansion. However, the company will need to navigate challenges such as data privacy, integration of disparate healthcare data, and maintaining data integrity to sustain its growth and success.
Use Clay to Get Funding Data
Sales professionals, leverage Clay's platform to access comprehensive fundraising data on companies like Verana Health and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
